A new private-label deal will see Hologic Inc. distributing a soft tissue biopsy instrument manufactured by Angiotech Pharmaceuticals Inc.
Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) inked a three-year, private-label deal with Bedford, Mass.-based Hologic Inc. (NSDQ:HOLX).
Under the terms of the agreement, Vancouver-based Angiotech will supply Hologic with its soft tissue biopsy device for breast biopsies. The deal is specific for products sold in the U.S. and will automatically renew after thee years, according to Angiotech.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The deal complements Hologic’s vacuum-assisted breast biopsy systems and expands its breast exam product offering with a “14g single-use, fully automatic biopsy instrument” with features including “a spring-loaded stylet and cannula, one-handed operation and an echogenic needle tip,”according to Angiotech.
There were approximately 1.8 million breast biopsies performed in the U.S. last year, according to Angiotech.
Last month Angiotech postponed payment of $9.7 million in interest on debt and a grappled with the possibility of de-listing from the NASDAQ stock exchange. The company also reported disappointing earnings for its 2010 third quarter, posting a net loss of $18.5 million, or 22 cents per diluted share, on sales of $59.0 million during the three months ended Sept. 30. That compares with a loss of $7.8 million, or 9 cents per diluted share, on sales of $63.2 million during the same period last year.
On Nov. 18 the company announced the sale of its Lifespan vascular graft business to LeMaitre Vascular Inc. (NSDQ:LMAT) for $3 million in November.
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.